R. Sherer

Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome.

F. Kocka, C. Kallick, P. Spencer, 1986, Annals of internal medicine.

Altered T-lymphocyte subsets in hospitalized intravenous drug abusers

P. Orris, M. Warzynski, D. McCulley, 1984 .

Isospora belli and Cryptosporidium sp. from a patient not suspected of having acquired immunodeficiency syndrome.

F. Kocka, C. Peters, C. Kallick, 1987, Diagnostic microbiology and infectious disease.

Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome.

F. Kocka, M. Mangkornkanok, R. Sherer, 1987, The American journal of gastroenterology.

It is Time to Recognize the Severity of Post-Acute Sequelae of COVID-19 (PASC)

R. Sherer, C. Lehmann, Rasika Karnik, 2022, The Open COVID Journal.

Polycythemia in patients infected with human immunodeficiency virus‐1

R. Sherer, P. Koduri, Caroline Teter, 2000, American journal of hematology.

A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)

W. El-Sadr, S. Caras, R. Luskin-Hawk, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cancer, transplant, and immunocompromising conditions were not significantly associated with severe illness or death in hospitalized COVID-19 patients

Maya R. Krasnow, Meng-qi Zhu, R. Sherer, 2021, Journal of Clinical Virology.